BioCentury
ARTICLE | Company News

Quadrant drug delivery news

February 1, 1999 8:00 AM UTC

QTH will divest its Quantison and Myomap diagnostic imaging products acquired in its acquisition of Andaris Ltd. (see BioCentury Nov. 16 and Oct. 5, 1998). Quantison is in Phase II trials to diagnose...